Ken Griffin Novo Cure LTD Transaction History

Citadel Advisors LLC

  • $618 Billion
  • Q3 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Novo Cure LTD stock. As of the latest transaction made, Citadel Advisors LLC holds 221,700 shares of NVCR stock, worth $2.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
221,700
Previous 894,148 75.21%
Holding current value
$2.51 Million
Previous $15.9 Million 82.0%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$10.9 - $18.46 $7.31 Million - $12.4 Million
-670,591 Reduced 75.0%
223,557 $2.89 Million
Q2 2025

Aug 14, 2025
BUY
$15.37 - $19.4 $8.81 Million - $11.1 Million
573,420 Added 178.79%
894,148 $15.9 Million
Q1 2025

May 15, 2025
BUY
$17.82 - $30.19 $4.75 Million - $8.05 Million
266,583 Added 492.35%
320,728 $5.72 Million
Q4 2024

Feb 14, 2025
BUY
$14.54 - $33.41 $786,512 - $1.81 Million
54,093 Added 104025.0%
54,145 $1.61 Million
Q3 2024

Nov 14, 2024
SELL
$15.61 - $23.34 $8.07 Million - $12.1 Million
-516,811 Reduced 99.99%
52 $0
Q2 2024

Aug 14, 2024
BUY
$11.83 - $24.05 $1.52 Million - $3.09 Million
128,524 Added 33.1%
516,863 $8.85 Million
Q1 2024

May 15, 2024
SELL
$12.42 - $17.29 $3.6 Million - $5.01 Million
-289,853 Reduced 42.74%
388,339 $6.07 Million
Q4 2023

Feb 14, 2024
BUY
$11.13 - $15.78 $79,924 - $113,316
7,181 Added 1.07%
678,192 $10.1 Million
Q3 2023

Nov 14, 2023
BUY
$16.15 - $42.35 $1.93 Million - $5.05 Million
119,275 Added 21.62%
671,011 $10.8 Million
Q2 2023

Aug 14, 2023
BUY
$40.29 - $82.51 $21.3 Million - $43.6 Million
528,223 Added 2246.51%
551,736 $22.9 Million
Q1 2023

May 15, 2023
BUY
$56.44 - $118.81 $1.22 Million - $2.57 Million
21,608 Added 1134.28%
23,513 $1.41 Million
Q4 2022

Feb 14, 2023
SELL
$63.98 - $85.37 $3.96 Million - $5.28 Million
-61,831 Reduced 97.01%
1,905 $139,000
Q3 2022

Nov 14, 2022
SELL
$67.99 - $89.57 $23.9 Million - $31.5 Million
-351,888 Reduced 84.66%
63,736 $4.84 Million
Q2 2022

Aug 15, 2022
BUY
$56.6 - $89.9 $3.83 Million - $6.08 Million
67,647 Added 19.44%
415,624 $28.9 Million
Q1 2022

May 16, 2022
BUY
$60.15 - $84.52 $13.3 Million - $18.7 Million
220,708 Added 173.42%
347,977 $28.8 Million
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $359,257 - $583,722
-4,785 Reduced 3.62%
127,269 $9.56 Million
Q3 2021

Nov 15, 2021
BUY
$116.17 - $194.55 $2.38 Million - $3.99 Million
20,505 Added 18.38%
132,054 $15.3 Million
Q2 2021

Aug 16, 2021
BUY
$130.4 - $225.58 $1.25 Million - $2.17 Million
9,605 Added 9.42%
111,549 $24.7 Million
Q1 2021

May 17, 2021
BUY
$124.11 - $190.17 $3.94 Million - $6.04 Million
31,777 Added 45.29%
101,944 $13.5 Million
Q4 2020

Feb 16, 2021
SELL
$112.16 - $174.14 $15.6 Million - $24.2 Million
-138,882 Reduced 66.44%
70,167 $12.1 Million
Q3 2020

Nov 16, 2020
BUY
$58.05 - $111.31 $5.51 Million - $10.6 Million
94,912 Added 83.16%
209,049 $23.3 Million
Q2 2020

Aug 14, 2020
BUY
$57.2 - $74.41 $527,670 - $686,432
9,225 Added 8.79%
114,137 $6.77 Million
Q1 2020

May 15, 2020
BUY
$57.05 - $95.75 $282,739 - $474,537
4,956 Added 4.96%
104,912 $7.07 Million
Q4 2019

Feb 14, 2020
BUY
$68.3 - $93.8 $5.32 Million - $7.31 Million
77,905 Added 353.29%
99,956 $8.42 Million
Q3 2019

Nov 14, 2019
SELL
$61.86 - $97.8 $736,257 - $1.16 Million
-11,902 Reduced 35.05%
22,051 $1.65 Million
Q2 2019

Aug 14, 2019
SELL
$42.22 - $63.23 $1.53 Million - $2.29 Million
-36,238 Reduced 51.63%
33,953 $2.15 Million
Q1 2019

May 15, 2019
SELL
$31.96 - $56.12 $6.08 Million - $10.7 Million
-190,225 Reduced 73.05%
70,191 $0
Q4 2018

Feb 14, 2019
BUY
$28.72 - $52.63 $5.72 Million - $10.5 Million
199,111 Added 324.79%
260,416 $8.72 Million
Q3 2018

Nov 13, 2018
SELL
$32.0 - $52.4 $19.6 Million - $32.1 Million
-612,031 Reduced 90.9%
61,305 $0
Q2 2018

Aug 10, 2018
SELL
$19.85 - $32.0 $10.3 Million - $16.6 Million
-518,951 Reduced 43.53%
673,336 $0
Q1 2018

May 11, 2018
BUY
$19.3 - $23.65 $14.4 Million - $17.7 Million
748,125 Added 168.44%
1,192,287 $26 Million
Q4 2017

Feb 09, 2018
BUY
$16.3 - $21.9 $4.44 Million - $5.97 Million
272,697 Added 159.04%
444,162 $8.97 Million
Q3 2017

Nov 09, 2017
BUY
$18.05 - $21.75 $3.09 Million - $3.73 Million
171,465
171,465 $3.4 Million

Others Institutions Holding NVCR

# of Institutions
290
Shares Held
74.2M
Call Options Held
1.26M
Put Options Held
247K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.19B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email